Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR.

Ostrow KL, Hoque MO, Loyo M, Brait M, Greenberg A, Siegfried JM, Grandis JR, Gaither Davis A, Bigbee WL, Rom W, Sidransky D.

Clin Cancer Res. 2010 Jul 1;16(13):3463-72. doi: 10.1158/1078-0432.CCR-09-3304. Epub 2010 Jun 30.

2.

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, Wood T, Jeronimo C, Rosenbaum E, Stern J, Yu M, Trink B, Kiviat NB, Sidransky D.

J Clin Oncol. 2006 Sep 10;24(26):4262-9. Epub 2006 Aug 14.

PMID:
16908936
3.

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.

Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D.

J Natl Cancer Inst. 2006 Jul 19;98(14):996-1004.

PMID:
16849682
4.

Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.

Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T.

Cancer Res. 2006 Mar 15;66(6):3338-44.

5.

Cancer statistics, 2006.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ.

CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30.

6.

Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.

Cirincione R, Lintas C, Conte D, Mariani L, Roz L, Vignola AM, Pastorino U, Sozzi G.

Int J Cancer. 2006 Mar 1;118(5):1248-53.

7.

Novel strategies for the early detection and prevention of lung cancer.

Wardwell NR, Massion PP.

Semin Oncol. 2005 Jun;32(3):259-68. Review.

PMID:
15988680
8.

Clinical practice. Lung cancer screening.

Mulshine JL, Sullivan DC.

N Engl J Med. 2005 Jun 30;352(26):2714-20. Review. No abstract available.

PMID:
15987920
9.

Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review.

Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albelda SM.

Clin Cancer Res. 2005 Jun 1;11(11):3974-86. Review.

10.

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.

Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR.

J Clin Oncol. 2004 Nov 15;22(22):4575-83.

PMID:
15542809
11.

Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer.

Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, Moon CS.

Clin Cancer Res. 2004 Apr 1;10(7):2284-8.

12.

Cancer epigenetics: DNA methylation and chromatin alterations in human cancer.

Esteller M.

Adv Exp Med Biol. 2003;532:39-49. Review.

PMID:
12908548
13.

Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.

Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, Sidransky D.

Clin Cancer Res. 2003 Apr;9(4):1370-5.

14.

The power and the promise of DNA methylation markers.

Laird PW.

Nat Rev Cancer. 2003 Apr;3(4):253-66. Review.

PMID:
12671664
15.

Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.

Brabender J, Usadel H, Metzger R, Schneider PM, Park J, Salonga D, Tsao-Wei DD, Groshen S, Lord RV, Takebe N, Schneider S, Hölscher AH, Danenberg KD, Danenberg PV.

Clin Cancer Res. 2003 Jan;9(1):223-7.

16.

Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients.

An Q, Liu Y, Gao Y, Huang J, Fong X, Li L, Zhang D, Cheng S.

Cancer Lett. 2002 Dec 15;188(1-2):109-14.

PMID:
12406555
17.

Aberrant DNA methylation in lung cancer: biological and clinical implications.

Zöchbauer-Müller S, Minna JD, Gazdar AF.

Oncologist. 2002;7(5):451-7. Review.

18.

DNA methylation analysis: a powerful new tool for lung cancer diagnosis.

Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA.

Oncogene. 2002 Aug 12;21(35):5450-61. Review.

19.

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.

Cancer Res. 2002 Apr 15;62(8):2370-7.

20.

Screening for lung cancer with low-dose spiral computed tomography.

Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS, Clayton AC, Pairolero PC.

Am J Respir Crit Care Med. 2002 Feb 15;165(4):508-13.

PMID:
11850344

Supplemental Content

Support Center